{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T17:14:16Z","timestamp":1793294056524,"version":"4.5.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T00:00:00Z","timestamp":1710460800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004271","name":"Sapienza University of Rome","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004271","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.biopha.2024.116441","type":"journal-article","created":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T08:38:53Z","timestamp":1711010333000},"page":"116441","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Intranasal administration of Escherichia coli Nissle expressing the spike protein of SARS-CoV-2 induces long-term immunization and prevents spike protein-mediated lung injury in mice"],"prefix":"10.1016","volume":"174","author":[{"given":"Giovanni","family":"Sarnelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Del Re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Palenca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia Basili","family":"Franzin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"Seguella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurora","family":"Zilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcella","family":"Pesce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Rurgo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Sanseverino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2024.116441_bib1","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41579-022-00713-0","article-title":"SARS-CoV-2 pathogenesis","volume":"20","author":"Lamers","year":"2022","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.biopha.2024.116441_bib2","first-page":"1","article-title":"mRNA vaccines in disease prevention and treatment","volume":"8","author":"Zhang","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.biopha.2024.116441_bib3","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/s41577-021-00592-1","article-title":"Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escape","volume":"21","author":"Tregoning","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biopha.2024.116441_bib4","doi-asserted-by":"crossref","first-page":"22777","DOI":"10.1038\/s41598-021-02321-z","article-title":"Comparing the clinical efficacy of COVID-19 vaccines: a systematic review and network meta-analysis","volume":"11","author":"Rotshild","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2024.116441_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.35772\/ghm.2021.01010","article-title":"COVID-19 vaccines: implementation, limitations and opportunities","volume":"3","author":"Richman","year":"2021","journal-title":"Glob. Health Med."},{"key":"10.1016\/j.biopha.2024.116441_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104298","article-title":"Tolerability and immunogenicity of an intranasally-administered adenovirus-vectored COVID-19 vaccine: An open-label partially-randomised ascending dose phase I trial","volume":"85","author":"Madhavan","year":"2022","journal-title":"eBioMedicine"},{"key":"10.1016\/j.biopha.2024.116441_bib7","doi-asserted-by":"crossref","first-page":"4042","DOI":"10.1016\/j.vaccine.2023.04.013","article-title":"Promises and challenges of mucosal COVID-19 vaccines","volume":"41","author":"Rathore","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.biopha.2024.116441_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2020.198141","article-title":"Prospect of SARS-CoV-2 spike protein: potential role in vaccine and therapeutic development","volume":"288","author":"Samrat","year":"2020","journal-title":"Virus Res."},{"key":"10.1016\/j.biopha.2024.116441_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2018.00783","article-title":"Outer membrane vesicles: current status and future direction of these novel vaccine adjuvants","volume":"9","author":"Tan","year":"2018","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.biopha.2024.116441_bib10","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1586\/14760584.2015.1026808","article-title":"Biosynthetically engineered lipopolysaccharide as vaccine adjuvant","volume":"14","author":"Zariri","year":"2015","journal-title":"Expert Rev. Vaccin."},{"key":"10.1016\/j.biopha.2024.116441_bib11","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.05826","article-title":"The unexhausted potential of E. coli","volume":"4","author":"Blount","year":"2015","journal-title":"eLife"},{"key":"10.1016\/j.biopha.2024.116441_bib12","doi-asserted-by":"crossref","first-page":"268","DOI":"10.2174\/138920111794295693","article-title":"Engineering of therapeutic proteins production in Escherichia coli","volume":"12","author":"Kamionka","year":"2011","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.biopha.2024.116441_bib13","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s10295-011-1082-9","article-title":"Industrial production of recombinant therapeutics in Escherichia coli and its recent advancements","volume":"39","author":"Huang","year":"2012","journal-title":"J. Ind. Microbiol. Biotechnol."},{"key":"10.1016\/j.biopha.2024.116441_bib14","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2025622118","article-title":"Killed whole-genome reduced-bacteria surface-expressed coronavirus fusion peptide vaccines protect against disease in a porcine model","volume":"118","author":"Maeda","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biopha.2024.116441_bib15","doi-asserted-by":"crossref","first-page":"569","DOI":"10.3390\/biom13030569","article-title":"Oral Immunization with Escherichia coli Nissle 1917 expressing SARS-CoV-2 spike protein induces mucosal and systemic antibody responses in mice","volume":"13","author":"Sarnelli","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.biopha.2024.116441_bib16","unstructured":"ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques - PubMed. https:\/\/pubmed.ncbi.nlm.nih.gov\/32731258\/."},{"key":"10.1016\/j.biopha.2024.116441_bib17","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/s41586-020-2622-0","article-title":"SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness","volume":"586","author":"Corbett","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2024.116441_bib18","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1080\/22221751.2020.1791738","article-title":"High neutralizing antibody titer in intensive care unit patients with COVID-19","volume":"9","author":"Liu","year":"2020","journal-title":"Emerg. Microbes Infect."},{"key":"10.1016\/j.biopha.2024.116441_bib19","unstructured":"Ziegler, C.G.K. et al. SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues. Cell 181, 1016-1035.e19 (2020)."},{"key":"10.1016\/j.biopha.2024.116441_bib20","unstructured":"Anti-Spike Mucosal IgA Protection against SARS-CoV-2 Omicron Infection - PubMed. https:\/\/pubmed.ncbi.nlm.nih.gov\/36103621\/."},{"key":"10.1016\/j.biopha.2024.116441_bib21","doi-asserted-by":"crossref","first-page":"7793","DOI":"10.1128\/JVI.00979-13","article-title":"Recombinant IgA is sufficient to prevent influenza virus transmission in guinea pigs","volume":"87","author":"Seibert","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.biopha.2024.116441_bib22","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1007\/s00011-020-01378-2","article-title":"Macrophage polarization and its role in the pathogenesis of acute lung injury\/acute respiratory distress syndrome","volume":"69","author":"Chen","year":"2020","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.biopha.2024.116441_bib23","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.3389\/fimmu.2020.01312","article-title":"The lung macrophage in SARS-CoV-2 infection: a friend or a foe?","volume":"11","author":"Abassi","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2024.116441_bib24","doi-asserted-by":"crossref","first-page":"L408","DOI":"10.1152\/ajplung.00225.2020","article-title":"SARS-CoV-2 (COVID-19) and cystic fibrosis","volume":"319","author":"Stanton","year":"2020","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.biopha.2024.116441_bib25","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.antiviral.2017.03.022","article-title":"The role of epidermal growth factor receptor (EGFR) signaling in SARS coronavirus-induced pulmonary fibrosis","volume":"143","author":"Venkataraman","year":"2017","journal-title":"Antivir. Res."},{"key":"10.1016\/j.biopha.2024.116441_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.01518","article-title":"Targeting the NLRP3 inflammasome in severe COVID-19","volume":"11","author":"Freeman","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2024.116441_bib27","unstructured":"SARS-CoV-2 drives NLRP3 inflammasome activation in human microglia through spike protein | Molecular Psychiatry. https:\/\/www.nature.com\/articles\/s41380-022-01831-0."},{"key":"10.1016\/j.biopha.2024.116441_bib28","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/s41422-021-00495-9","article-title":"SARS-CoV-2 spike protein interacts with and activates TLR41","volume":"31","author":"Zhao","year":"2021","journal-title":"Cell Res."},{"key":"10.1016\/j.biopha.2024.116441_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e21893","article-title":"SARS-CoV-2 activates the TLR4\/MyD88 pathway in human macrophages: a possible correlation with strong pro-inflammatory responses in severe COVID-19","volume":"9","author":"Sahanic","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.biopha.2024.116441_bib30","unstructured":"SARS-CoV-2 Spike protein induces TLR4-mediated long-term cognitive dysfunction recapitulating post-COVID-19 syndrome in mice - PubMed. https:\/\/pubmed.ncbi.nlm.nih.gov\/36857178\/."},{"key":"10.1016\/j.biopha.2024.116441_bib31","doi-asserted-by":"crossref","first-page":"592","DOI":"10.3390\/metabo11090592","article-title":"Ultramicronized palmitoylethanolamide inhibits NLRP3 inflammasome expression and pro-inflammatory response activated by SARS-CoV-2 spike protein in cultured murine alveolar macrophages","volume":"11","author":"Del Re","year":"2021","journal-title":"Metabolites"},{"key":"10.1016\/j.biopha.2024.116441_bib32","doi-asserted-by":"crossref","first-page":"6893","DOI":"10.1002\/ptr.7302","article-title":"Cannabidiol inhibits SARS-Cov-2 spike (S) protein-induced cytotoxicity and inflammation through a PPAR\u03b3-dependent TLR4\/NLRP3\/Caspase-1 signaling suppression in Caco-2 cell line","volume":"35","author":"Corpetti","year":"2021","journal-title":"Phytother. Res. PTR"},{"key":"10.1016\/j.biopha.2024.116441_bib33","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/eji.202149655","article-title":"The presence of serum anti-SARS-CoV-2 IgA appears to protect primary health care workers from COVID-19","volume":"52","author":"Hennings","year":"2022","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.biopha.2024.116441_bib34","doi-asserted-by":"crossref","first-page":"87","DOI":"10.4103\/0976-500X.72350","article-title":"Blood sample collection in small laboratory animals","volume":"1","author":"Parasuraman","year":"2010","journal-title":"J. Pharmacol. Pharmacother."},{"key":"10.1016\/j.biopha.2024.116441_bib35","doi-asserted-by":"crossref","DOI":"10.1101\/pdb.prot100271","article-title":"Sampling and preparation of mouse and rat serum","volume":"2017","author":"Greenfield","year":"2017","journal-title":"Cold Spring Harb. Protoc."},{"key":"10.1016\/j.biopha.2024.116441_bib36","doi-asserted-by":"crossref","first-page":"520","DOI":"10.3389\/fphys.2017.00520","article-title":"Body temperature measurements for metabolic phenotyping in mice","volume":"8","author":"Meyer","year":"2017","journal-title":"Front. Physiol."},{"key":"10.1016\/j.biopha.2024.116441_bib37","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1086\/430615","article-title":"Antibody avidity maturation during severe acute respiratory syndrome\u2013associated coronavirus infection","volume":"192","author":"Chan","year":"2005","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.biopha.2024.116441_bib38","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1093\/infdis\/jiaa581","article-title":"SARS-CoV-2 Antibody avidity responses in COVID-19 patients and convalescent plasma donors","volume":"222","author":"Benner","year":"2020","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.biopha.2024.116441_bib39","doi-asserted-by":"crossref","first-page":"6765","DOI":"10.1002\/jmv.27270","article-title":"Vaccination versus infection with SARS-CoV-2: Establishment of a high avidity IgG response versus incomplete avidity maturation","volume":"93","author":"Struck","year":"2021","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.biopha.2024.116441_bib40","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1179\/his.2009.32.4.186","article-title":"Comparison of various tissue-preparation techniques for cryosectioning of frozen mouse tissues","volume":"32","author":"Ling","year":"2009","journal-title":"J. Histotechnol."},{"key":"10.1016\/j.biopha.2024.116441_bib41","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1165\/rcmb.2009-0210ST","article-title":"An Official American Thoracic Society workshop report: features and measurements of experimental acute lung injury in animals","volume":"44","author":"Matute-Bello","year":"2011","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.biopha.2024.116441_bib42","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11481-020-09979-8","article-title":"ACE-2-interacting domain of SARS-CoV-2 (AIDS) peptide suppresses inflammation to reduce fever and protect lungs and heart in mice: implications for COVID-19 therapy","volume":"16","author":"Paidi","year":"2021","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.biopha.2024.116441_bib43","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0160-5402(85)90029-4","article-title":"Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium","volume":"14","author":"Mullane","year":"1985","journal-title":"J. Pharmacol. Methods"},{"key":"10.1016\/j.biopha.2024.116441_bib44","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s10753-011-9378-5","article-title":"Bronchoalveolar lavage total cell count in interstitial lung diseases--does it matter?","volume":"35","author":"Domaga\u0142a-Kulawik","year":"2012","journal-title":"Inflammation"},{"key":"10.1016\/j.biopha.2024.116441_bib45","doi-asserted-by":"crossref","first-page":"13931","DOI":"10.3390\/ijms241813931","article-title":"A novel probiotic-based oral vaccine against SARS-CoV-2 omicron variant B.1.1.529","volume":"24","author":"Chau","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2024.116441_bib46","doi-asserted-by":"crossref","first-page":"466","DOI":"10.3390\/vaccines9050466","article-title":"Probiotic-based vaccines may provide effective protection against COVID-19 acute respiratory disease","volume":"9","author":"Taghinezhad-S","year":"2021","journal-title":"Vaccines"},{"key":"10.1016\/j.biopha.2024.116441_bib47","article-title":"Antiviral effects and underlying mechanisms of probiotics as promising antivirals","volume":"12","author":"Wang","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.biopha.2024.116441_bib48","doi-asserted-by":"crossref","first-page":"3941","DOI":"10.1007\/s00253-019-09770-7","article-title":"Targeting ideal oral vaccine vectors based on probiotics: a systematical view","volume":"103","author":"Jiang","year":"2019","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.biopha.2024.116441_bib49","doi-asserted-by":"crossref","first-page":"184","DOI":"10.3390\/cells12010184","article-title":"Probiotics mechanism of action on immune cells and beneficial effects on human health","volume":"12","author":"Mazziotta","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.biopha.2024.116441_bib50","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2021.789242","article-title":"Boosting vaccine-elicited respiratory mucosal and systemic COVID-19 immunity in mice with the oral Lactobacillus plantarum","volume":"8","author":"Xu","year":"2021","journal-title":"Front. Nutr."},{"key":"10.1016\/j.biopha.2024.116441_bib51","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/all.13502","article-title":"Intranasal administration of probiotic Lactobacillus rhamnosus GG prevents birch pollen-induced allergic asthma in a murine model","volume":"74","author":"Spacova","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/j.biopha.2024.116441_bib52","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12929-023-00958-8","article-title":"Intranasal administration of Lactobacillus johnsonii attenuates hyperoxia-induced lung injury by modulating gut microbiota in neonatal mice","volume":"30","author":"Chen","year":"2023","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.biopha.2024.116441_bib53","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.antiviral.2011.11.004","article-title":"Intranasal administration of live Lactobacillus species facilitates protection against influenza virus infection in mice","volume":"93","author":"Youn","year":"2012","journal-title":"Antivir. Res."},{"key":"10.1016\/j.biopha.2024.116441_bib54","doi-asserted-by":"crossref","first-page":"14789","DOI":"10.1038\/s41598-023-41763-5","article-title":"Efficient symptomatic treatment and viral load reduction for children with influenza virus infection by nasal-spraying Bacillus spore probiotics","volume":"13","author":"Tran","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2024.116441_bib55","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1186\/s12931-019-1203-y","article-title":"Unique patterns of lower respiratory tract microbiota are associated with inflammation and hospital mortality in acute respiratory distress syndrome","volume":"20","author":"Kyo","year":"2019","journal-title":"Respir. Res."},{"key":"10.1016\/j.biopha.2024.116441_bib56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-023-01668-1","article-title":"Lung microbiome: new insights into the pathogenesis of respiratory diseases","volume":"9","author":"Li","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.biopha.2024.116441_bib57","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1007\/s43440-022-00415-7","article-title":"Short-chain fatty acids\u2013microbiota crosstalk in the coronavirus disease (COVID-19)","volume":"74","author":"W\u0142odarczyk","year":"2022","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.biopha.2024.116441_bib58","doi-asserted-by":"crossref","unstructured":"Helmy, Y.A., Kassem, I.I. & Rajashekara, G. Immuno-modulatory effect of probiotic E. coli Nissle 1917 in polarized human colonic cells against Campylobacter jejuni infection. Gut Microbes 13, 1857514.","DOI":"10.1080\/19490976.2020.1857514"},{"key":"10.1016\/j.biopha.2024.116441_bib59","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1128\/IAI.73.3.1452-1465.2005","article-title":"Escherichia coli Nissle 1917 distinctively modulates T-cell cycling and expansion via toll-like receptor 2 signaling","volume":"73","author":"Sturm","year":"2005","journal-title":"Infect. Immun."},{"key":"10.1016\/j.biopha.2024.116441_bib60","unstructured":"Anti-inflammatory modulation of immune response by probiotic Escherichia coli Nissle 1917 in human blood mononuclear cells - Anne-Katrin G\u00fcttsches, Stefan L\u00f6seke, Ulrich Z\u00e4hringer, Ulrich Sonnenborn, Corinne Enders, S\u00f6ren Gatermann, Albrecht Bufe, 2012. https:\/\/journals.sagepub.com\/doi\/10.1177\/1753425910396251."},{"key":"10.1016\/j.biopha.2024.116441_bib61","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.femsim.2004.10.023","article-title":"Intestinal immunity of Escherichia coli NISSLE 1917: a safe carrier for therapeutic molecules","volume":"43","author":"Westendorf","year":"2005","journal-title":"FEMS Immunol. Med. Microbiol."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224003251?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224003251?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T23:03:21Z","timestamp":1782342201000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332224003251"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":61,"alternative-id":["S0753332224003251"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116441","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intranasal administration of Escherichia coli Nissle expressing the spike protein of SARS-CoV-2 induces long-term immunization and prevents spike protein-mediated lung injury in mice","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116441","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"116441"}}